Another Loss For Pharma In 'Induce' Kickback Law Challenge

By Dan McKay · January 19, 2024, 10:57 PM EST

The pharmaceutical industry lost another round in court in recent days amid a forceful push to narrow enforcement of the Anti-Kickback Statute, leaving the status quo in place for now but...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Pharmaceutical Coalition for Patient Access v. United States of America et al.

Case Number

3:22-cv-00714

Court

Virginia Eastern

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

November 09, 2022

Recent Articles By Dan

December 20, 2024
3rd Circ. Denies Challenge To Pa. Autism Settlement
December 19, 2024
FDA Declaration May Restart Compounders' Shortage Suit
December 17, 2024
New Fed Health Data Rules: What You Need To Know
December 17, 2024
FDA Sharpens Focus On Celebrity Drug Endorsements
December 10, 2024
FDA Drug Approval Guidance: What You Need to Know
December 09, 2024
19 Republican AGs Win Order Against DACA Health Coverage
December 03, 2024
GOP-Backed Medicaid Job Mandate Could Reshuffle Care
November 26, 2024
Trump FDA Pick Devoted To Healthcare Price Transparency
November 19, 2024
No 'Tin Hats': Fluoride Ruling Offers Options As RFK Eyes Ban
November 15, 2024
Teva Defends Mifepristone Antitrust Case Against Corcept